The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MLN9708, an investigational proteasome inhibitor, in patients (pts) with solid tumors: Updated phase I results.
David C. Smith
Research Funding - Millennium
Daniel Sullivan
No relevant relationships to disclose
Jeffrey R. Infante
No relevant relationships to disclose
John S. Kauh
No relevant relationships to disclose
Lillian L. Siu
Research Funding - Millennium
Gordana Vlahovic
Consultant or Advisory Role - Genentech
John A. Thompson
Research Funding - Millennium
Neeraj Gupta
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
Alessandra Di Bacco
Employment or Leadership Position - Millennium
Guohui Liu
Employment or Leadership Position - Millennium
Thea Kalebic
Employment or Leadership Position - Millennium